Tactoset® Injectable Bone Substitute
K-Number: K231968 · 2023-12-20
ApplicantAnika Therapeutics, Inc.
Decision Date2023-12-20
Product CodeMQV
Advisory CommitteeOR
DecisionSubstantially Equivalent
Device Summary
Tactoset® Injectable Bone Substitute is a medical device manufactured by Anika Therapeutics, Inc.. It received FDA 510(k) clearance on 2023-12-20 under approval number K231968. The device is classified under product code MQV. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the Tactoset® Injectable Bone Substitute?
Tactoset® Injectable Bone Substitute is a medical device that received FDA 510(k) clearance on 2023-12-20. It is manufactured by Anika Therapeutics, Inc.. The 510(k) number is K231968.
When was Tactoset® Injectable Bone Substitute approved by the FDA?
Tactoset® Injectable Bone Substitute received FDA 510(k) clearance on 2023-12-20, under approval number K231968.
What company makes Tactoset® Injectable Bone Substitute?
Tactoset® Injectable Bone Substitute is manufactured by Anika Therapeutics, Inc..
What is the FDA product code for Tactoset® Injectable Bone Substitute?
The FDA product code for Tactoset® Injectable Bone Substitute is MQV.
Other Devices by Anika Therapeutics, Inc.
Related Devices (Code: MQV)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.